4//SEC Filing
Howes Barbara 4
Accession 0000899243-20-015876
CIK 0001746473other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 9:03 PM ET
Size
12.4 KB
Accession
0000899243-20-015876
Insider Transaction Report
Form 4
Howes Barbara
Chief Human Resource Officer
Transactions
- Conversion
Common Stock
2020-06-05+3,821→ 24,799 total - Award
Stock Option (right to buy)
2020-03-31+7,584→ 7,584 totalExercise: $6.22Exp: 2030-03-30→ Common Stock (7,584 underlying) - Award
Series C Preferred Stock
2020-02-27$13.08/sh+27,322$357,495→ 27,322 total→ Common Stock (3,821 underlying) - Conversion
Series C Preferred Stock
2020-06-05−27,322→ 0 total→ Common Stock (3,821 underlying)
Footnotes (3)
- [F1]The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series C Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock had no expiration date.
- [F2]On May 22, 2020, the Issuer completed a one-for-7.15 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.
- [F3]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 31, 2020 (or if there is no corresponding day in any such month, on the last day of such month), subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
PLIANT THERAPEUTICS, INC.
CIK 0001746473
Entity typeother
Related Parties
1- filerCIK 0001809147
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 9:03 PM ET
- Size
- 12.4 KB